Strahil Hristov Berkov,Jaime Bastida Armengol,Carlos Codina Mahrer,Jean Paulo De Andrade,Rudolf Leonardus Maria Berbee
申请号：
US14910116
公开号：
US20170182111A1
申请日:
2013.10.09
申请国别(地区):
US
年份:
2017
代理人:
摘要：
A composition of extracts from the genus Hippeastrum and their components is intended for the production of pharmaceuticals and dietary supplements. The composition consists of galanthamine from 40% to 98%, haemanthamine from 0.01% to 35%, narwedine from 0.01% to 10%, and/or other alkaloids of homolycorine-, and/or tazettine-, and/or monthanine- and/or haemanthamine- and/or galanthamine- and/or lycorine-type from 0.001% to 35%, and non-alkaloid plant metabolites from 0.001 to 1%, derived from the total extract of the genus Hippeastrum. The alkaloid content can vary from 0.01% to 99% and non-alkaloid plant metabolites and/or other inactive excipients and/or solvents from 1% to 99.9%, respectively. The composition may be in dry or liquid form. It is used to isolate pure compounds of haemanthamine and galanthamine.
